1 / 15
-Supplementary material
826.5: b6 b5 b4 a6 a5 y2 y72+ b72+ b62+ y3/a62+ y4 b2 DacR V Y I H P F b2 b4b5b6b7 y2 y4 y7 y3 235.1 263.1 364.3 413.8 466.3 535.9 576.4 669.5 689.5 782.6 798.6 827.5 0.0 0.5 1.0 1.5 2.0 x105 200 300 400 500 600 700 800 900 1000 1100 m/zFigure S-1: MS/MS spectrum of doubly-charged AII1 (m/z 545.0, 31.7 min) from the sample
of acetylated angiotensin II without subsequent treatment in a boiling water bath. The acetylated N-terminal residue is marked with “ac”. The b6 ion (m/z 826.5), most intense ion of
2 / 15 -868.5: b6 y2 b5 a6 a5 b4 y3 y5 y4 b3 b72+ y6 b2 b62+ a62+ y72+ DacR V YacI H P F b2b3 b4b5b6b7 y2 y3 y4 y5 y6 y7 263.1 364.2 434.7 487.3 556.9 618.4 711.5 731.5 824.5 840.5 869.5 0.0 0.5 1.0 1.5 x106 200 300 400 500 600 700 800 900 1000 1100 m/z
Figure S-2: MS/MS spectrum of doubly-charged AII2 (m/z 565.9, 34.0 min) from the sample
of acetylated angiotensin II without subsequent treatment in a boiling water bath. The acetylated residues are marked with “ac”. The b6 ion (m/z 868.5), most intense ion of the
3 / 15 -y2 y3 y4 y5 y6 y72+ 910.6: b6 b3/b62+ b5 a6 a5 b4 b2 235.2 263.1 356.0 381.8 400.3 455.8478.8 508.3 532.4 578.0 599.3 616.4 660.4689.6 745.5 773.4 817.6 866.7 882.5 911.6 0 1000 2000 3000 4000 5000 200 300 400 500 600 700 800 900 1000 1100 m/z DacRacV YacI H P F b2 b3 b4b5b6 y2 y3 y4 y5 y6 y7 R1 N H R2 O N H N H NH2 R1 N H R2 O N H N H NH O Arginine Acetylated arginine
Figure S-3: MS/MS spectrum of doubly-charged AII3 (m/z 586.9, 34.6 min) from the sample
of acetylated angiotensin II without subsequent treatment in a boiling water bath. The acetylated residues are marked with “ac”. The b6 ion (m/z 910.6), most intense ion of the
spectrum, is truncated (ion counts: 1.5 × 104). We propose a structure of acetylated arginine as an insert.
4 / 15 -868.5: b6 y2 b5 a6 a5 b4 y3 y4 b72+ b62+ y72+ 235.0 263.1 364.2 434.9 487.3 556.9 618.3 647.4 683.5 711.5 731.5 775.5 809.5 824.5 840.6 869.6 1172.4 0.0 0.5 1.0 1.5 2.0 2.5 200 300 400 500 600 700 800 900 1000 1100 m/z x104 DacR V YacI H P F b4b5b6b7 y2 y3 y4 y7
Figure S-4: MS/MS spectrum of doubly-charged AII2 (m/z 565.9, 32.3 min) from the sample
of acetylated angiotensin II after 15 min of treatment in a boiling water bath. The acetylated residues are marked with “ac”. The b6 ion (m/z 868.5), most intense ion of the spectrum, is
5 / 15 -b8 b7 b6 a7 b82+ b5 b4 b3 b2 a3 a2 y8 a8 y7 y6 y5 y4 y3 b92+ y82+ y92+ <E H W SacY KacL R P G-NH 2 b2b3 b4 b5 b6 b7b8 y3 y4 y5 y6 y7 b9 y8 y9 220.9 249.0 328.2 435.2 504.2 545.3 583.9 611.5 660.6 744.4 774.6 897.5 918.6 1010.6 1089.7 1166.7 0 1 2 3 4 5 200 300 400 500 600 700 800 900 1000 1100 m/z x104
Figure S-5: MS/MS spectrum of doubly-charged K6-LHRH2 (m/z 669.5, 29.3 min) from the
sample of acetylated (D-Lys6)-luteinizing hormone-releasing hormone without subsequent treatment in a boiling water bath. The acetylated residues are marked with “ac”.
6 / 15 -b7 b6 a7 b82+ b5 b4 b3 b2 a3 a2 y8 y7 y6 y5 y4 y3 b92+ y82+ a6 y6 - 42 a82+ 221.0 249.0 328.2 435.3 566.4 604.9 660.4 681.4 709.4 774.5 816.6 885.6 939.5 1024.6 1052.6 1131.7 0.0 0.5 1.0 1.5 200 300 400 500 600 700 800 900 1000 1100 m/z x105 <E H W SacYacKacL R P G-NH 2 b2b3 b4 b5 b6 b7b8 y3 y4 y5 y6 y7 b9 y8
Figure S-6: MS/MS spectrum of doubly-charged K6-LHRH3 (m/z 690.5, 32.0 min) from the
sample of acetylated (D-Lys6)-luteinizing hormone-releasing hormone without subsequent treatment in a boiling water bath. The acetylated residues are marked with “ac”. The peak with the m/z of y6 minus 42 Da is likely the result of in-source fragmentation of the tyrosyl acetate.
7 / 15 -249.1 371.3 435.2 483.3 503.9 565.5 605.3 626.3 653.4 682.0 702.3 745.5 859.7 939.5 987.8 1023.9 1052.6 1173.8 0 500 1000 1500 200 300 400 500 600 700 800 900 1000 1100 m/z y3 b2 b3 b4 b6 b7 b82+ y4 y5 <E H W SacYacKacL RacP G-NH 2 b2b3 b4 b6 b7b8 y3 y4 y5
Figure S-7: MS/MS spectrum of doubly-charged K6-LHRH4 (m/z 711.4, 32.4 min) from the
sample of acetylated (D-Lys6)-luteinizing hormone-releasing hormone without subsequent treatment in a boiling water bath. The acetylated residues are marked with “ac”.
8 / 15 -b7 b6 a7 b82+ b5 b4 b3 b2 a2 y8 y7 y6 y4 y3 y5/b92+ y82+ b8 249.1 328.2 441.4 524.6 562.9 611.5 639.4 667.4 690.5 774.6 855.5 968.6 1047.7 1124.7 0.0 0.2 0.4 0.6 0.8 1.0 1.2 200 300 400 500 600 700 800 900 1000 1100 m/z x105 <E H W S Y KacL R P G-NH 2 b2b3 b4b5 b6 b7b8 y3 y4 y5 y6 y7 b9 y8
Figure S-8: MS/MS spectrum of doubly-charged K6-LHRH1 (m/z 648.5, 28.2 min) from the
sample of acetylated (D-Lys6)-luteinizing hormone-releasing hormone after 15 min of treatment in a boiling water bath. The acetylated lysine residue is marked with “ac”.
9 / 15 -b7 y8 b8 y7 b2 a2 b3 a3 y4 b4 y82+ y6 a7 b82+ y3 y5 b5 <E H W dA Y KacL R P G-NH 2 b2b3 b4 b5 b7b8 y3 y4 y5 y6 y7 y8 221.0 249.0 328.2 407.3 435.2 504.2 553.9 611.5 630.6 667.3 774.5 843.6 950.6 1029.7 1106.7 0.00 0.25 0.50 0.75 1.00 1.25 200 300 400 500 600 700 800 900 1000 1100 m/z N H O O O R1 R2 O N H O O R1 R2 Dehydroalanine (dA) ß-elimination Acetylated serine ×105
Figure S-9: MS/MS spectrum of doubly-charged K6-LHRH1* (m/z 639.4, 29.4 min) from the
sample of acetylated (D-Lys6)-luteinizing hormone-releasing hormone after 60 min of treatment in a boiling water bath. The acetylated lysine residue is marked with “ac”. ‘dA’ stands for ‘dehydroalanine’. The structures of acetylated arginine and dehydroalanine are proposed as an insert.
10 / 15
-Note S-10: Occurrence in proteins of hydroxyl-containing amino acids in an “activating” position. The occurrence in proteins of His, Ser, Tyr and Thr is respectively 2.2%, 7.1%, 3.2% and 5.7%1. Therefore the occurrence of a His-Xaa-OHaa or OHaa-Xaa-His triad (where OHaa is Ser, Tyr or Thr and Xaa may be any amino acid) is calculated as: 2 × 0.022 × (0.071 + 0.032 + 0.057) = 0.00704. Therefore such a triad may be statistically expected every 0.00704-1 (i.e. about 142) amino acids.
1. Clementi, C.; Carloni, P.; Maritan, A., Protein design is a key factor for subunit-subunit association. Proc Natl Acad Sci U S A 1999, 96, (17), 9616-21.
11 / 15 -261.2 319.2 381.5 465.8 489.4 558.3 586.4 642.4 699.8 756.2 794.1 832.1 890.2 910.2 946.0 981.7 1031.3 1088.7 1122.1 0.00 0.25 0.50 0.75 1.00 1.25 200 300 400 500 600 700 800 900 1000 1100 m/z L KacP L A Q S H A T KacH KacI P I KacYacL E y2 y3 y4 y6 b2 b3 b15b16 b17 b18 y2 b183+ y3 y4 b2 b3 b193+ b162+ b172+ b182+ y182+ ×105
Figure S-11: MS/MS spectrum of triply-charged peptide
(LKacPLAQSHATKacHKacIPIKacYacLE, m/z 843.0, 58.0 min) from a sample of acetylated horse heart myoglobin prior to treatment in a boiling water bath. The acetylated residues are marked with “ac”.
12 / 15 -261.1 332.2 529.3 603.4 732.5 758.0 775.9 808.5 834.4 877.0 926.3 954.0 976.2 1016.6 1040.0 1077.9 0.25 0.50 0.75 1.00 1.25 x106 200 300 400 500 600 700 800 900 1000 1100 m/z b303+ /y303+ b283+ b273+ b263+ b253+ b243+ b233+ b223+ b2/y2 y3 y4 y5 y6 y283+ b293+ /y293+ b304+ /y304+ b294+ /y294+ F I S D A I I H V L H S KacH P G D F G A D A Q G A MoxT KacA L E y2 y3 y4 y5 y6 b30 b29 b27 b25 b26 b24 b23 b22 y29 y30 y28 b28
Figure S-12: MS/MS spectrum of quadruply-charged peptide
(FISDAIIHVLHSKacHPGDFGADAQGAMoxTKacALE, m/z 845.5, 61.5 min) from a sample of acetylated horse heart myoglobin after 60 min of incubation in a boiling water bath. The acetylated residues are marked with “ac”, and the oxidized methionine is marked with “ox”.
13 / 15 -×105 261.2 332.1 604.3 713.6 781.7 819.0 842.4 891.2 914.7 938.3 979.6 1054.0 1091.8 0 1 2 3 4 5 6 200 300 400 500 600 700 800 900 1000 1100 m/z b303+ /y303+ b293+ /y293+ b304+ /y304+ b294+ /y294+ b283+ b273+ b263+ b253+ b233+ b223+ b213+ b2/y2 y3 b284+ y284+ y6 y8 F I S D A I I H V L H SacKacH P G D F G A D A Q G A MoxT KacA L E y2 y3 y8 y6 b30 b29 b27 b25 b26 b23 b22 y29 y30 y28 b28
Figure S-13: MS/MS spectrum of quadruply-charged peptide
(FISDAIIHVLHSacKacHPGDFGADAQGAMoxTKacALE, m/z 856.0, 62.6 min) from a sample of acetylated horse heart myoglobin after 60 min of incubation in a boiling water bath. The acetylated residues are marked with “ac”, and the oxidized methionine is marked with “ox”.
14 / 15 -A E MoxKacA S E D L KacKacH G T V V L T A L G G I L I KacKacKacG H H E A E y3 y4 y6 y30 y29 y31 b3 290.1 320.2 348.3 365.2 394.4 429.2 461.3 485.3 518.5 546.4571.3 589.3 615.3 644.4 698.0 737.0 766.2 795.6 826.0 840.7 900.2 933.9 959.0 997.7 1041.0 1069.6 1092.9 1150.3 0 1 2 3 4 200 300 400 500 600 700 800 900 1000 1100 m/z y313+ y303+ y293+ y283+ y273+ y263+ y28 y27y26 y253+ y25 y223+ y24 y23 y233+y243+ y22 b3/y3 y4 y6 b4 b5 b4 b5 5 ×105
Figure S-14: MS/MS spectrum of quadruply-charged peptide
(AEMoxKacASEDLKacKacHGTVVLTALGGILIKacKacKacGHHEAE, m/z 949.8, 68.6 min) from a sample of acetylated horse heart myoglobin after 60 min of incubation in a boiling water bath. The acetylated residues are marked with “ac”, and the oxidized methionine is marked with “ox”.
15 / 15 -327.2 417.3 474.2 513.3 672.4 726.5 828.0 873.5 915.4 941.8 976.9 991.2 1043.7 1142.6 0 1 2 3 4 200 300 400 500 600 700 800 900 1000 1100 m/z b172+ b162+ b10 y3 y4 b6 b142+ y5 b 132+ b7 y6 b8 y7 b9 acG L S D G E W Q Q V L N V W G KacV E y3 y4 y5 y6 y7 b9b10 b13b14 b16 b17 b6 b7 b8 ×105
Figure S-15: MS/MS spectrum of doubly-charged peptide
(acGLSDGEWQQVLNVWGKacVE, m/z 1065.0, 81.7 min) from a sample of acetylated horse heart myoglobin after 60 min of incubation in a boiling water bath. The acetylated residues are marked with “ac”.